跳至主要内容
临床试验/ACTRN12610001022055
ACTRN12610001022055招募中4 期

For patients with ureteral stent insertion after ureteroscopic stone manipulations, is Solifenacin effective in relieving ureteral stent-related symptoms?

Mennonite Christian Hospital, Taiwan0 个研究点目标入组 100 人开始时间: 2010年11月22日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • From 01/10/2010 to 30/10/2011, all patients with unilateral ureteral stones to be treated with ureteroscopy where temporary stenting is indicated will be considered for enrollment in the study.

排除标准

  • Patients who had significant ureteral trauma, a preexisting ureteral stent, another secondary surgical procedure that would have impacted patient comfort, ie transurethral resection of the prostate or of bladder tumor, or urinary infection or chronic pain history will be excluded from study.

研究者

发起方
Mennonite Christian Hospital, Taiwan

相似试验